The BBCIC Science Committee develops and implements the consortium’s research and publication plans. The Science Committee consists of scientific experts from BBCIC’s participating organizations.
Resources that support BBCIC’s effort to engage data consortium, managed care specialty drug experts, researchers, and industry to monitor biosimilars.
Current research: Oncology data fitness and descriptive analysis. The consortium will evaluate the current data capabilities of the BBCIC distributed research networks and identify additional data sources to enrich BBCIC capabilities in measures relevant to oncology outcome.
BBCIC is a non-profit research consortium that monitors the safety and effectiveness of biosimilars and novel biologics and provides the assurance needed to determine which medications deliver the best health outcomes.
